FinancialContent is the trusted provider of stock market information to the media industry.
Nasdaq Halts Moleculin Biotech Inc.

NEW YORK, May 18, 2020 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market® (Nasdaq: NDAQ) announced that the trading halt status in Moleculin Biotech Inc. (Nasdaq: MBRX) was changed to "additional information requested" from the company. Trading in the company’s stock had been halted on May 4, 2020 at 9:25:06 Eastern Time at a last sale price of $1.07.

Trading will remain halted until Moleculin Biotech Inc.has fully satisfied Nasdaq’s request for additional information.

For news and additional information about the company, please contact the company directly or check under the company’s symbol using InfoQuotesSM on the Nasdaq® Web site.

For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at


Nasdaq Media Contact:
Bianca Fata

Data & News supplied by
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.